MannKind | MNKD - Ordinary Share Capital

Stock Price
2.77
Daily Change
-0.01 -0.18%
Monthly
-50.09%
Yearly
-47.23%
Q1 Forecast
2.69

MannKind reported $307.83M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Adma Biologics USD 236.62M 242K Dec/2024
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Insmed USD 214.26M 1.67M Dec/2025
Karyopharm Therapeutics USD 13K 0 Sep/2024
MacroGenics USD 63.26M 62.63M Sep/2025
MannKind USD 307.83M 806K Dec/2025
Merck USD 2.49B 15.79M Sep/2025
Minerva Neurosciences USD 1000 0 Sep/2024
Novavax USD 162.58M 106K Dec/2025
Novo Nordisk DKK 4.44B 3.99B Jun/2025
Pfizer USD 5.69B 1000K Sep/2025
Xencor USD 71.87M 529K Dec/2025